| abstract |
The technology disclosed herein generally relates to the field of pain relief, and relates to a topical composition comprising a TRPV1 antagonist. The technology disclosed herein provides for methods, compositions and devices for topical application for the treatment of pain, allodynia or hyperalgesia associated with acute tissue injury, e.g., for the treatment of a wounds or tissue injury, including but not limited to incision, abrasion, laceration, puncture and avulsion. The methods, compositions and devices disclosed herein can be used for point-of-care treatment of a tissue injury or wound, e.g., in emergency care for first responders, emergency medical technicians (EMTs), ambulance workers, firemen, in field surgery, combat medicine or casualty care and/or first aid kits. |